New REDUCE-IT® Analyses Show VASCEPA® (icosapent e

-- Analysis Also Found IPE Was Associated with a 41% Reduction in Total Events Compared with Placebo --

Related Keywords

United Kingdom , Netherlands , Denmark , China , Dublin , Ireland , Austria , Lebanon , United States , New Jersey , Sweden , Spain , Finland , Philadelphia , Pennsylvania , United Arab Emirates , Canada , Switzerland , Americans , Great Britain , Scotland , American , Mark Marmur , Clin Cardiol , Coll Cardiol , A Report From The American Heart Association , European Union , Drug Administration , American Heart Association , Amarin Corporation , Nasdaq , Exchange Commission , Also Found , Total Events Compared , Almost Exclusively Comprised , Established Cardiovascular , Scientific Data , Clinical Use , Reduce Cardiovascular , Presented Today , Scientific Sessions , Simultaneously Published , European Heart Journal , Metabolic Syndrome , United Arab , Private Securities Litigation Reform Act , Securities Act , Clinic Metabolic Syndrome , Its Individual Components , Renal Function , Heart Disease , Stroke Statistics , Report From , American Heart , Cardiovascular Events , Icosapent Ethyl , Cardiovascular Risk Reduction , Total Ischemic Events , Region ,